Seeking Alpha

Danone suitors down to a pair

  • Nestle (NSRGY) and Fresenius are the last two potential buyers of Danone's $5.5B Medical Nutrition business still standing.
  • Nestle is already a big player in the market while Fresenius says the Danone business will complement its Kabi division that makes tube and IV feeding equipment and generic infusion drugs.
  • Danone will likely use the proceeds to expand its baby food and dairy businesses.
  • Unsurprisingly, the parties decline to comment at this time.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs